Clobetasone
From Wikipedia, the free encyclopedia
 |
|
|
Clobetasone
|
|
| Systematic (IUPAC) name | |
| (8S,9R,10S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-9-fluoro-17-hydroxy-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthrene-3,11-dione | |
| Identifiers | |
| CAS number | |
| ATC code | D07 S01BA09 |
| PubChem | |
| Chemical data | |
| Formula | C22H26ClFO4 |
| Mol. mass | 408.891 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | topical |
Clobetasone (INN[1]) is a corticosteroid used in dermatology, for treating such skin inflammation as seen in eczema and other forms of dermatitis, and ophthalmology.
It is available as clobetasone butyrate under the brand name Eumovate[2] or Trimovate,[3] both manufactured by GlaxoSmithKline.
[edit] References
- ^ United Nations Statistics Division - Classifications Registry - Alphabetical index for HS 2002 Entries starting with 'C' (page 310 of 422)
- ^ Eumovate cream/ointment, NetDoctor.co.uk
- ^ Trimovate cream, NetDoctor.co.uk
 |
This medical treatment article is a stub. You can help Wikipedia by expanding it. |
